BOURGEON CAPITAL MANAGEMENT LLC - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 77 filers reported holding ORAMED PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.

Quarter-by-quarter ownership
BOURGEON CAPITAL MANAGEMENT LLC ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$14,687
-27.1%
5,6270.0%0.00%
-40.0%
Q2 2023$20,145
+64.2%
5,6270.0%0.01%
+66.7%
Q1 2023$12,267
-81.9%
5,6270.0%0.00%
-82.4%
Q4 2022$67,693
+88.0%
5,6270.0%0.02%
+70.0%
Q3 2022$36,000
+38.5%
5,6270.0%0.01%
+42.9%
Q2 2022$26,000
-46.9%
5,6270.0%0.01%
-36.4%
Q1 2022$49,000
-38.8%
5,6270.0%0.01%
-31.2%
Q4 2021$80,000
-35.5%
5,6270.0%0.02%
-40.7%
Q3 2021$124,000
+65.3%
5,6270.0%0.03%
+68.8%
Q2 2021$75,000
+31.6%
5,6270.0%0.02%
+23.1%
Q1 2021$57,000
+137.5%
5,6270.0%0.01%
+116.7%
Q4 2020$24,000
+60.0%
5,6270.0%0.01%
+20.0%
Q3 2020$15,000
-25.0%
5,6270.0%0.01%
-28.6%
Q2 2020$20,000
+17.6%
5,6270.0%0.01%
-22.2%
Q1 2020$17,000
-41.4%
5,6270.0%0.01%
-35.7%
Q4 2019$29,000
+61.1%
5,6270.0%0.01%
+40.0%
Q3 2019$18,0005,6270.01%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
MORGAN JESS S & CO INC 290,501$2,513,0001.83%
Knoll Capital Management, LLC 20,000$173,0000.11%
Private Portfolio Partners LLC 42,250$365,4630.09%
Rossmore Private Capital 40,661$352,0000.06%
OCCUDO QUANTITATIVE STRATEGIES LP 54,233$469,0000.04%
Cubist Systematic Strategies, LLC 241,892$2,092,0000.02%
TWO SIGMA ADVISERS, LP 662,000$5,726,0000.02%
TWO SIGMA INVESTMENTS, LP 550,956$4,766,0000.01%
Jump Financial, LLC 34,800$301,0000.01%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 264,824$2,291,0000.01%
View complete list of ORAMED PHARMACEUTICALS INC shareholders